← Back to Nuqta Atlas
Editorially curated · ae-abu-dhabi-newborn-genetic-screening
Abu Dhabi Newborn Genetic Screening Programme
Genome-based newborn screening intended to identify actionable childhood disorders before symptoms and connect families to confirmatory care.
01 / Project overview
What the record establishes.
- Geographic scope
- Abu Dhabi emirate; initial sites at Kanad Hospital and Danat Al Emarat
- Project type
- clinical genome screening program
- Research domain
- newborn genomics and rare-disease early detection
- Years
- 2025–
- Lifecycle status
- active phased rollout
- Status basis
- DoH launched the programs on 18 August 2025 and identified the first participating hospitals.
- Status evidence date
- 2025-08-18
- Scale
- Whole-genome screening for more than 815 treatable childhood-onset conditions; participant count not yet reported.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Department of Health - Abu Dhabi
- Partner organizations
- M42 · Kanad Hospital · Danat Al Emarat Hospital for Women and Children
- Organism / population
- newborn infants in participating Abu Dhabi hospitals
03 / Data and access
What exists and how it can be reached.
Data types
- whole-genome sequencing
- newborn screening
- clinical confirmation
Data access
Clinical results; no public research dataset identified.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Named genome-wide newborn screening program with a defined disease scope and implementation sites.
Editorial note
Clinical program, not a public cohort. Distinct from Dubai's Little Falcon rapid diagnostic project.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0